ECOLAB INC.
Business
ECOLAB INC. provides water, hygiene and infection prevention solutions and services that protect people and critical resources and improve operational efficiency and sustainability. It offers science‑based chemical products, cleaning and sanitizing programs, water and process treatment technologies, digital monitoring and dispensing equipment, food safety and contamination control solutions, and pest elimination services. The company organizes operations into four reportable segments: Global Industrial; Global Institutional & Specialty; Global Healthcare & Life Sciences; and Global Pest Elimination. Its offerings are sold worldwide through direct field and corporate account sales, third‑party distributors, and a network of manufacturing and distribution centers.
Summary from filing dated 2025-02-21
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 16,081 | 15,741 | 15,320 | 14,188 | 12,733 | |
| Cost of sales (including special charges (a)) | 8,931 | 8,900 | 9,155 | 8,831 | 7,616 | |
| Selling, general and administrative expenses | 4,258 | 4,228 | 4,062 | 3,654 | 3,416 | |
| Special (gains) and charges | 155 | −189 | 111 | 141 | 103 | |
| Operating income | 2,738 | 2,802 | 1,992 | 1,563 | 1,599 | |
| Other (income) expense | −51 | −51 | −60 | −25 | −34 | |
| Interest expense, net | 241 | 283 | 297 | 244 | 218 | |
| Income before income taxes | 2,548 | 2,571 | 1,756 | 1,343 | 1,414 | |
| Provision for income taxes | 455 | 439 | 363 | 235 | 270 | |
| Net income including noncontrolling interest | 2,093 | 2,132 | 1,393 | 1,109 | 1,144 | |
| Net income attributable to noncontrolling interest | 18 | 20 | 21 | 17 | 14 | |
| Net income attributable to Ecolab | 2,076 | 2,112 | 1,372 | 1,092 | 1,130 | |
| Basic (in dollars per share) | 7.33 | 7.43 | 4.82 | 3.83 | 3.95 | |
| Diluted EPS (in dollars per share) | 7.28 | 7.37 | 4.79 | 3.81 | 3.91 | |
| Basic (in shares) | 283 | 284 | 285 | 285 | 286 | |
| Diluted (in shares) | 285 | 287 | 287 | 287 | 289 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 646 | 1,257 | 920 | 599 | 360 | |
| Accounts receivable, net | 3,249 | 2,865 | 2,834 | 2,698 | 2,478 | |
| Inventories | 1,490 | 1,465 | 1,497 | 1,793 | 1,492 | |
| Other current assets | 570 | 439 | 393 | 405 | 357 | |
| Total current assets | 5,956 | 6,026 | 5,644 | 5,494 | 4,687 | |
| Property, plant and equipment, net | 4,277 | 3,752 | 3,475 | 3,293 | 3,289 | |
| Goodwill | 9,227 | 7,907 | 8,148 | 8,013 | 8,064 | |
| Other intangible assets, net | 3,689 | 3,309 | 3,494 | 3,681 | 4,224 | |
| Operating lease assets | 766 | 723 | 554 | 448 | 397 | |
| Other assets | 783 | 670 | 533 | 535 | 546 | |
| Total assets | 24,696 | 22,388 | 21,847 | 21,464 | 21,206 | |
| Short-term debt | 870 | 616 | 630 | 505 | 411 | |
| Accounts payable | 2,071 | 1,810 | 1,566 | 1,728 | 1,384 | |
| Compensation and benefits | 722 | 727 | 656 | 494 | 510 | |
| Income taxes | 134 | 127 | 159 | 198 | 104 | |
| Other current liabilities | 1,738 | 1,513 | 1,335 | 1,286 | 1,144 | |
| Total current liabilities | 5,535 | 4,793 | 4,346 | 4,210 | 3,553 | |
| Long-term debt | 7,366 | 6,949 | 7,551 | 8,075 | 8,347 | |
| Pension and postretirement benefits | 546 | 635 | 652 | 670 | 894 | |
| Deferred income taxes | 330 | 280 | 418 | 506 | 622 | |
| Operating lease liabilities | 597 | 576 | 426 | 338 | 283 | |
| Other liabilities | 519 | 366 | 382 | 406 | 254 | |
| Total liabilities | 14,892 | 13,599 | 13,774 | 14,206 | 13,953 | |
| Commitments and contingencies (Note 15) | — | — | — | — | — | |
| Common stock | 369 | 368 | 366 | 365 | 364 | |
| Additional paid-in capital | 7,521 | 7,160 | 6,767 | 6,580 | 6,465 | |
| Retained earnings | 12,834 | 11,517 | 10,075 | 9,319 | 8,815 | |
| Accumulated other comprehensive loss | −1,874 | −1,982 | −1,850 | −1,727 | −1,635 | |
| Treasury stock | −9,080 | −8,305 | −7,313 | −7,301 | −6,784 | |
| Total Ecolab shareholders' equity | 9,771 | 8,757 | 8,045 | 7,236 | 7,224 | |
| Noncontrolling interest | 34 | 32 | 28 | 23 | 29 | |
| Total equity | 9,805 | 8,789 | 8,072 | 7,259 | 7,253 | |
| Total liabilities and equity | 24,696 | 22,388 | 21,847 | 21,464 | 21,206 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation | 673 | 635 | 617 | 619 | 604 | |
| Amortization | 304 | 301 | 307 | 320 | 239 | |
| Deferred income taxes | −33 | −191 | −56 | −143 | −1 | |
| Share-based compensation expense | 137 | 135 | 95 | 88 | 90 | |
| Pension and postretirement plan contributions | −78 | −54 | −109 | −64 | −60 | |
| Pension and postretirement plan expense (income), net | 15 | 14 | 3 | 46 | 42 | |
| Restructuring charges, net of cash paid | 19 | 24 | −33 | 66 | −42 | |
| Sale of global surgical solutions business | 1 | −382 | — | — | — | |
| Other, net | 29 | 24 | 32 | 25 | 16 | |
| Accounts receivable | −186 | −147 | −84 | −320 | −178 | |
| Inventories | 36 | −116 | 320 | −403 | −73 | |
| Other assets | 84 | −24 | 72 | −278 | −93 | |
| Accounts payable | 68 | 300 | −232 | 395 | 200 | |
| Other liabilities | −208 | 163 | 87 | 329 | 144 | |
| Cash provided by operating activities | 2,953 | 2,814 | 2,412 | 1,788 | 2,062 | |
| Capital expenditures | −1,048 | −995 | −775 | −713 | −643 | |
| Property and other assets sold | 52 | 11 | 10 | 2 | 12 | |
| Acquisitions and investments in affiliates, net of cash acquired | −1,621 | −313 | −180 | −7 | −3,924 | |
| Divestiture of businesses, net of cash divested | −15 | 890 | — | — | — | |
| Other, net | −75 | −27 | −45 | 1 | −25 | |
| Cash used for investing activities | −2,707 | −434 | −991 | −717 | −4,580 | |
| Net issuances (repayments) of commercial paper and notes payable | 98 | 2 | −2 | −404 | 394 | |
| Long-term debt borrowings | 1,046 | — | — | 494 | 2,775 | |
| Long-term debt repayments | −674 | −630 | −500 | — | −1,018 | |
| Reacquired shares | −784 | −987 | −14 | −518 | −107 | |
| Dividends paid | −754 | −664 | −617 | −603 | −566 | |
| Exercise of employee stock options | 228 | 259 | 97 | 29 | 144 | |
| Hedge settlements | — | −600,000 | −15 | 172 | 26 | |
| Other, net | −14 | −4 | −3 | −7 | −15 | |
| Cash used for financing activities | −853 | −2,024 | −1,055 | −837 | 1,603 | |
| Effect of exchange rate changes on cash and cash equivalents | −3 | −19 | −46 | 4 | 14 | |
| (Decrease) Increase in cash and cash equivalents | −611 | 337 | 321 | 239 | — | |
| Income taxes paid | 548 | 647 | 469 | 309 | 276 | |
| Net interest paid | 303 | 343 | 325 | 222 | 209 |